These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37113876)

  • 1. Cross-sectional study of COVID-19 infection in patients with rheumatic diseases in a sample of a Damascene population, Syria.
    Khalayli N; Kudsi M
    Ann Med Surg (Lond); 2023 Apr; 85(4):689-693. PubMed ID: 37113876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.
    Fredi M; Cavazzana I; Moschetti L; Andreoli L; Franceschini F;
    Lancet Rheumatol; 2020 Sep; 2(9):e549-e556. PubMed ID: 32838307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study.
    Hsu TY; D'Silva KM; Patel NJ; Wang J; Mueller AA; Fu X; Prisco L; Martin L; Vanni KMM; Zaccardelli A; Cook C; Choi HK; Zhang Y; Gravallese EM; Wallace ZS; Sparks JA
    Lancet Rheumatol; 2021 Sep; 3(9):e638-e647. PubMed ID: 34095857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical course and prognostic factors of COVID-19 infection in patients with chronic inflammatory-rheumatic disease: A retrospective, case-control study.
    Nas K; Güçlü E; Keskin Y; Dilek G; Kalçık Unan M; Can N; Tekeoğlu İ; Kamanlı A
    Arch Rheumatol; 2023 Mar; 38(1):44-55. PubMed ID: 37235113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
    El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
    Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.
    Bartovská Z; Andrle F; Beran O; Zlámal M; Řezáč D; Murinova I; Holub M
    Epidemiol Mikrobiol Imunol; 2020; 69(4):164-171. PubMed ID: 33445940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Methylprednisolone on Mortality and Clinical Courses in Patients with Severe COVID-19: A Propensity Score Matching Analysis.
    Li X; Yuan X; Xu Z; Shi L; Huang L; Lu X; Fu J
    Infect Dis Immun; 2023 Jan; 3(1):20-28. PubMed ID: 36789030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
    Avouac J; Drumez E; Hachulla E; Seror R; Georgin-Lavialle S; El Mahou S; Pertuiset E; Pham T; Marotte H; Servettaz A; Domont F; Chazerain P; Devaux M; Claudepierre P; Langlois V; Mekinian A; Maria ATJ; Banneville B; Fautrel B; Pouchot J; Thomas T; Flipo RM; Richez C; ;
    Lancet Rheumatol; 2021 Jun; 3(6):e419-e426. PubMed ID: 33786454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study.
    Jorge A; D'Silva KM; Cohen A; Wallace ZS; McCormick N; Zhang Y; Choi HK
    Lancet Rheumatol; 2021 Feb; 3(2):e131-e137. PubMed ID: 33392516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest X-ray Severity Score as a Putative Predictor of Clinical Outcome in Hospitalized Patients: An Experience From a Vietnamese COVID-19 Field Hospital.
    Hoang SV; Nguyen KM; Huynh TM; Huynh KLA; Nguyen PH; Tran HPN
    Cureus; 2022 Mar; 14(3):e23323. PubMed ID: 35464539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study.
    Mathew J; Jain S; Susngi T; Naidu S; Dhir V; Sharma A; Jain S; Sharma SK
    Rheumatol Adv Pract; 2023; 7(1):rkad025. PubMed ID: 36908302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
    Alzahrani ZA; Alghamdi KA; Almaqati AS
    Rheumatol Int; 2021 Jun; 41(6):1097-1103. PubMed ID: 33856543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes.
    Zehra T; Siddique SK; Aamir R; Mahmood A; Kiani AH; Virk ST
    Cureus; 2021 Mar; 13(3):e13720. PubMed ID: 33833931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of hospital admissions for COVID-19 pneumonia by chest radiographic scoring in a Johannesburg tertiary hospital.
    Labuschagne HC; Venturas J; Moodley H
    S Afr Med J; 2023 Feb; 113(2):75-83. PubMed ID: 36757072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study.
    Alhowaish TS; Alhamadh MS; Alhabeeb AY; Aldosari SF; Masuadi E; Alrashid A
    Cureus; 2022 Jun; 14(6):e26343. PubMed ID: 35903564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.